Patents by Inventor Chengliang Dai

Chengliang Dai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREDICTING EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN CANCER PATIENTS
    Publication number: 20190170752
    Abstract: Disclosed is a method for predicting clinical response of a cancer patient to treatment with an immune checkpoint inhibitor, or a combination of two or more thereof, or with a combination of an immune checkpoint inhibitor and other antitumor drugs, by introducing bispecific T cell engager (BiTE) into the platform of lymphocytes containing T cells in vitro, which are cultured on feeder cells or in Matrigel®.
    Type: Application
    Filed: July 31, 2017
    Publication date: June 6, 2019
    Applicant: BeiGene, Ltd.
    Inventors: Lusong Luo, Chengliang Dai, Zhijian Sun